Listed

BioNexus Gene Lab Corp

BGLCNasdaqCIK 1737523HealthcareFiscal year ends Dec 31

Reports and events: 101 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

BioNexus Gene Lab Corp, Reports and events
FiledFormWhat it isAccession number
2024-05-3119:45 ET10-K/AAnnual report, amendedPeriod 2022-12-310001477932-24-003418
2024-05-1517:20 ET10-QQuarterly reportPeriod 2024-03-310001477932-24-002941
2024-05-0916:37 ET8-K3.01 Delisting notice0001477932-24-002622
2024-04-1817:44 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001477932-24-002229
2024-04-1617:00 ET10-KAnnual reportPeriod 2023-12-310001477932-24-002151
2024-04-0119:59 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001477932-24-001695
2024-03-2619:59 ET10-Q/AQuarterly report, amendedPeriod 2023-09-300001477932-24-001468
2024-01-1722:43 ETSC 13DOwnership report, active investor0001477932-24-000214
2023-11-2022:10 ET10-QQuarterly reportPeriod 2023-09-300001477932-23-008709
2023-11-1318:40 ET8-K3.01 Delisting notice0001477932-23-008275
2023-11-0314:55 ET8-K5.02 Departure or appointment of officers or directors0001477932-23-008068
2023-10-3016:14 ET8-K/A5.02 Departure or appointment of officers or directors0001477932-23-007962
2023-10-1614:04 ET8-K5.02 Departure or appointment of officers or directors0001477932-23-007651
2023-10-1114:02 ET8-K5.02 Departure or appointment of officers or directors0001477932-23-007555
2023-09-0715:17 ET8-K5.02 Departure or appointment of officers or directors0001477932-23-006695
2023-08-1615:26 ET10-QQuarterly reportPeriod 2023-06-300001477932-23-006208
2023-07-2421:28 ET8-K1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001477932-23-005506
2023-07-2015:29 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001477932-23-005435
2023-07-1723:20 ETS-1/ARegistration statement, amended0001477932-23-005323
2023-07-0523:16 ETS-1/ARegistration statement, amended0001477932-23-004992
2023-05-0915:39 ET10-QQuarterly reportPeriod 2023-03-310001477932-23-003193
2023-05-0922:58 ETS-1/ARegistration statement, amended0001477932-23-003180
2023-03-3113:57 ET10-KAnnual reportPeriod 2022-12-310001477932-23-002002
2023-02-1419:37 ETS-1Registration statement0001477932-23-000981
2022-11-1421:38 ET10-QQuarterly reportPeriod 2022-09-300001477932-22-008532
2022-08-1519:57 ET10-QQuarterly reportPeriod 2022-06-300001477932-22-006097
2022-08-1519:35 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001477932-22-006086
2022-05-1612:27 ET10-QQuarterly reportPeriod 2022-03-310001477932-22-003360
2022-04-0612:16 ET10-KAnnual reportPeriod 2021-12-310001477932-22-002089
2021-11-1511:07 ET10-QQuarterly reportPeriod 2021-09-300001477932-21-008128
2021-08-1214:18 ET10-QQuarterly reportPeriod 2021-06-300001477932-21-005366
2021-05-1814:18 ET10-QQuarterly reportPeriod 2021-03-310001477932-21-003380
2021-03-3021:06 ET10-KAnnual reportPeriod 2020-12-310001477932-21-001795
2021-03-1120:54 ET8-K/A1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001477932-21-001370
2021-01-0716:00 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 9.01 Financial statements and exhibits0001477932-21-000091
2020-12-3019:09 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001477932-20-007556
2020-12-2212:32 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001477932-20-007424
2020-12-1016:00 ET8-K5.02 Departure or appointment of officers or directors0001477932-20-007190
2020-11-0914:12 ET10-Q/AQuarterly report, amendedPeriod 2020-09-300001477932-20-006341
2020-11-0314:20 ET10-QQuarterly reportPeriod 2020-09-300001477932-20-006210
2020-10-0815:32 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001477932-20-005798
2020-08-1113:41 ET10-QQuarterly reportPeriod 2020-06-300001477932-20-004715
2020-05-0815:35 ET10-QQuarterly reportPeriod 2020-03-310001477932-20-002455
2020-03-3117:12 ET10-KAnnual reportPeriod 2019-12-310001477932-20-001729
2019-11-1414:31 ET10-QQuarterly reportPeriod 2019-09-300001477932-19-006454
2019-10-1520:00 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001477932-19-005881
2019-08-0919:22 ET10-QQuarterly reportPeriod 2019-06-300001551163-19-000195
2019-05-1517:15 ET10-QQuarterly reportPeriod 2019-03-310001551163-19-000126
2019-03-2716:02 ETS-1/ARegistration statement, amended0001551163-19-000051
2019-02-2520:30 ETS-1/ARegistration statement, amended0001551163-19-000043

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.